• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在晚期卵巢癌中,具有预后价值的生物因子 uPAR、uPAR-del4/5 和 rab31 的 mRNA 表达水平与临床无关。

mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer.

机构信息

Institut für Pathologie, Technische Universität Dresden, D-01307 Dresden, Germany.

出版信息

Biol Chem. 2011 Nov;392(11):1047-51. doi: 10.1515/BC.2011.166.

DOI:10.1515/BC.2011.166
PMID:21848504
Abstract

High tumor tissue mRNA expression of the tumor biological factors uPAR, uPAR-del4/5, or rab31 is associated with shorter distant metastasis-free and overall survival in breast cancer patients. To evaluate whether these factors are also clinically relevant in ovarian cancer, we quantified the respective mRNA levels in primary tumor tissue of advanced ovarian cancer patients (n=103) and evaluated their association with clinicopathological parameters and patients' prognosis. mRNA expression levels of all three markers did not show any significant association with overall or progression-free survival, demonstrating that these factors have no prognostic value in advanced ovarian cancer.

摘要

高肿瘤组织中肿瘤生物学因子 uPAR、uPAR-del4/5 或 rab31 的 mRNA 表达与乳腺癌患者的无远处转移生存期和总生存期较短相关。为了评估这些因素在卵巢癌中是否也具有临床相关性,我们在晚期卵巢癌患者(n=103)的原发肿瘤组织中定量了各自的 mRNA 水平,并评估了它们与临床病理参数和患者预后的关系。这三个标志物的 mRNA 表达水平与总生存期或无进展生存期均无显著相关性,表明这些因素在晚期卵巢癌中没有预后价值。

相似文献

1
mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer.在晚期卵巢癌中,具有预后价值的生物因子 uPAR、uPAR-del4/5 和 rab31 的 mRNA 表达水平与临床无关。
Biol Chem. 2011 Nov;392(11):1047-51. doi: 10.1515/BC.2011.166.
2
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor.尿激酶受体剪接变体uPAR-del4/5相关基因在乳腺癌中的表达:鉴定rab31作为独立预后因素
Breast Cancer Res Treat. 2008 Sep;111(2):229-40. doi: 10.1007/s10549-007-9782-6. Epub 2007 Oct 20.
3
Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.尿激酶受体 mRNA 剪接变异体 uPAR-del4/5 的过表达影响乳腺癌细胞在体外和体内的肿瘤相关过程。
Breast Cancer Res Treat. 2011 Jun;127(3):649-57. doi: 10.1007/s10549-010-1042-5. Epub 2010 Jul 16.
4
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.uPAR-del4/5和TIMP-3 mRNA表达水平在乳腺癌中的预后相关性
Eur J Cancer. 2005 Nov;41(17):2760-8. doi: 10.1016/j.ejca.2005.09.002. Epub 2005 Oct 26.
5
Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes.尿激酶受体剪接变体 uPAR-del4/5 在乳腺癌细胞中的过表达以剂量依赖的方式影响细胞黏附和侵袭,并调节肿瘤相关基因的转录。
Biol Chem. 2012 Dec;393(12):1449-55. doi: 10.1515/hsz-2012-0206.
6
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.乳腺肿瘤组织基质中的尿激酶系统与乳腺癌细胞侵袭
Int J Oncol. 2009 Jan;34(1):15-23.
7
Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer.一种新型尿激酶受体剪接变体的鉴定及其在乳腺癌中的预后相关性。
Thromb Haemost. 2003 Apr;89(4):705-17.
8
High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.尿激酶型纤溶酶原激活物及其同源受体的高表达与甲状腺乳头状癌的晚期和较短无病间期相关。
J Clin Endocrinol Metab. 2011 Feb;96(2):504-8. doi: 10.1210/jc.2010-1688. Epub 2010 Nov 24.
9
Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.胃癌中尿激酶型纤溶酶原受体、白细胞介素-8基因表达与临床病理特征的关系
Oncology. 2004;66(3):210-7. doi: 10.1159/000077997.
10
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer.尿激酶型纤溶酶原激活物受体在肿瘤组织中的高浓度与卵巢癌患者的良好预后相关。
Int J Cancer. 2003 Nov 20;107(4):658-65. doi: 10.1002/ijc.11420.

引用本文的文献

1
Overexpression of RAB31 in gastric cancer is associated with released exosomes and increased tumor cell invasion and metastasis.胃癌中 RAB31 的过表达与释放的外泌体以及肿瘤细胞侵袭和转移的增加有关。
Cancer Med. 2023 Jun;12(12):13497-13510. doi: 10.1002/cam4.6007. Epub 2023 May 24.
2
Association between rs9965664 polymorphism and immunoglobulin therapy resistance in patients with Kawasaki disease.川崎病患者rs9965664基因多态性与免疫球蛋白治疗抵抗的相关性
Front Cardiovasc Med. 2022 Oct 18;9:944508. doi: 10.3389/fcvm.2022.944508. eCollection 2022.
3
Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study.
化疗前可溶性尿激酶型纤溶酶原激活物受体的临床实用性和预测潜力评估:观察性单中心研究。
Biomol Biomed. 2023 Mar 16;23(2):287-297. doi: 10.17305/bjbms.2022.7857.
4
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.白血病细胞中作为竞争性内源RNA发挥作用的尿激酶型纤溶酶原激活物受体(uPAR)变体的鉴定
Cancers (Basel). 2022 Apr 14;14(8):1980. doi: 10.3390/cancers14081980.
5
High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.Rab31 高表达预示着口腔鳞状细胞癌不良的预后,并促进细胞增殖和侵袭。
Oncol Rep. 2021 Mar;45(3):1182-1192. doi: 10.3892/or.2021.7940. Epub 2021 Jan 18.
6
SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer.SRPX2和RAB31是胰腺癌有效的预后生物标志物。
J Cancer. 2019 Jun 2;10(12):2670-2678. doi: 10.7150/jca.32072. eCollection 2019.
7
Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.SWATH-MS 技术在 miR-26a 敲除 HeLa 细胞中蛋白质表达变化的无标记定量分析。
Sci Rep. 2019 Feb 4;9(1):1399. doi: 10.1038/s41598-018-34904-8.
8
GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer.GeneExpressScore 特征:胃癌中稳健的预后和预测分类器。
Mol Oncol. 2018 Nov;12(11):1871-1883. doi: 10.1002/1878-0261.12351. Epub 2018 Sep 28.
9
Rab-mediated vesicle trafficking in cancer.Rab介导的囊泡运输与癌症
J Biomed Sci. 2016 Oct 6;23(1):70. doi: 10.1186/s12929-016-0287-7.
10
The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression.Rab31在癌症进展中细胞增殖和凋亡中的关键作用
Mol Neurobiol. 2016 Sep;53(7):4431-7. doi: 10.1007/s12035-015-9378-9. Epub 2015 Aug 6.